Lasezkay George M Insider Trades

Insider Trading History

Track insider trading activity for Lasezkay George M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $205k 500,000 shares
Last Trade
Jan 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$485k 500,000 shares
$0.97
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $191k 466,577 shares
Last Trade
Jan 19, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.9k 18,000 shares
$1.27
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $180k 439,500 shares
Last Trade
Jan 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$567k 439,500 shares
$1.29
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $82k 200,000 shares
Last Trade
Sep 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 200,000 shares
$0.85
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $199k 484,577 shares
Last Trade
Jan 19, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.2k 20,030 shares
$1.46
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $200k 487,500 shares
Last Trade
Jan 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$722k 487,500 shares
$1.48
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $207k 504,607 shares
Last Trade
Jan 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.9k 10,800 shares
$2.12
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $211k 515,407 shares
Last Trade
Jan 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$641k 292,500 shares
$2.19
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $171k 417,907 shares
Last Trade
Jan 11, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.5k 5,100 shares
$2.46
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $173k 423,007 shares
Last Trade
Sep 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.8k 3,525 shares
$6.46
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $175k 426,532 shares
Last Trade
Jun 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.2k 3,707 shares
$4.38
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $176k 430,239 shares
Last Trade
Mar 19, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.5k 3,370 shares
$2.82
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $178k 433,609 shares
Last Trade
Mar 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.2k 6,000 shares
$3.37
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $180k 439,609 shares
Last Trade
Jan 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 284,750 shares
$4.01
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $123k 299,359 shares
Last Trade
Dec 21, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.89k 3,330 shares
$2.07
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
CEO
Holding Value $124k 302,689 shares
Last Trade
Sep 22, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$21.3k 13,411 shares
$1.59
$0.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up